Its rise marked a dramatic shift from local Covid-19 patterns over the last year and a half, in which cases have been caused by a “soup” of Omicron sub-variants circulating together.
“We always knew this was a possibility, but we didn’t know for sure whether it was going to happen or not,” Plank said of JN.1′s dominance.
The sub-variant emerged from a similarly-mutated Omicron strain, BA.2.86 - of which JN.1 was separated by just a single mutation in the spike protein the virus used to enter our cells.
A descendant of JN.1 - JN.1.4 - has since been detected in New Zealand and overseas, but was thought to have only an incremental advantage over its parent.
“Although this is the first time in 18 months that we’ve had a variant sweep through, it hasn’t had anything like the health impact that BA.5 did,” Plank said.
“It’s clearly got a growth advantage and some degree of immune advantage, but it’s not causing the same level of severe illness that we saw in the past.”
The difference partly owed to more people having been exposed to the virus since 2022, he said.
Otago University evolutionary virologist Dr Jemma Geoghegan said JN.1 was similarly dominant elsewhere in the world, indicating Covid-19 hadn’t settled into a seasonal pattern like other respiratory diseases.
“This shows that we’re still in these pandemic waves, driven by the evolution of the virus.”
While surveillance showed Covid-19 infection rates remained elevated across New Zealand, there were indications the country was past the peak of the wave, with hospitalisations and wastewater detections trending downward nationally.
Te Whatu Ora’s latest update showed 245 Covid-19 cases in hospital at midnight Sunday - around half the number reported in mid-January.
Just as JN.1 helped add momentum to the surge, Plank said it was also possible it could shorten its tail – meaning the wave’s decline might not prove as gradual as its build-up.
The latest Omicron-targeted booster wasn’t yet available in New Zealand, despite being in use elsewhere – but experts say the current shot remained effective in preventing severe disease.
Jamie Morton is a specialist in science and environmental reporting. He joined the Herald in 2011 and writes about everything from conservation and climate change to natural hazards and new technology.